10x Genomics (TXG) Other Non-Current Assets (2018 - 2026)

10x Genomics has disclosed Other Non-Current Assets across 9 years of filings, most recently posting $2.6 million for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $2.6 million, up 14.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.6 million (up 14.29% YoY), and the FY2025 annual result was $2.9 million, down 29.45% from the prior year.
• Other Non-Current Assets came in at $2.6 million for Q1 2026 at 10x Genomics, down from $2.9 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $61.0 million in Q4 2023 to a low of $1.9 million in Q3 2025.
• The 5-year median for Other Non-Current Assets is $3.1 million (2022), against an average of $7.2 million.
• Peak annual rise in Other Non-Current Assets reached 83.36% in 2024, while the deepest fall reached 93.23% in 2024.
• 10x Genomics' Other Non-Current Assets stood at $2.9 million in 2022, then surged by 2002.03% to $61.0 million in 2023, then slumped by 93.23% to $4.1 million in 2024, then retreated by 29.45% to $2.9 million in 2025, then dropped by 9.92% to $2.6 million in 2026.
• The last three Other Non-Current Assets figures came in at $2.6 million (Q1 2026), $2.9 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.